These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 18523740)
21. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update. Tsuji Y; Dobrev D Vasc Health Risk Manag; 2013; 9():165-75. PubMed ID: 23637539 [TBL] [Abstract][Full Text] [Related]
22. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
26. Dronedarone: a promising alternative for the management of atrial fibrillation. Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399 [TBL] [Abstract][Full Text] [Related]
27. Novel anti-arrhythmic medications in the treatment of atrial fibrillation. Saklani P; Skanes A Curr Cardiol Rev; 2012 Nov; 8(4):302-9. PubMed ID: 22920483 [TBL] [Abstract][Full Text] [Related]
28. Vernakalant hydrochloride for the treatment of atrial fibrillation. Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903 [TBL] [Abstract][Full Text] [Related]
29. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492 [TBL] [Abstract][Full Text] [Related]
30. Spotlight on intravenous vernakalant in recent-onset atrial fibrillation. Duggan ST; Scott LJ Drugs Aging; 2011 Jun; 28(6):501-4. PubMed ID: 21639409 [TBL] [Abstract][Full Text] [Related]
32. Dronedarone: a new antiarrhythmic agent. Zareba KM Drugs Today (Barc); 2006 Feb; 42(2):75-86. PubMed ID: 16541184 [TBL] [Abstract][Full Text] [Related]
33. Dronedarone for atrial fibrillation: a new therapeutic agent. Patel PD; Bhuriya R; Patel DD; Arora BL; Singh PP; Arora RR Vasc Health Risk Manag; 2009; 5():635-42. PubMed ID: 19688104 [TBL] [Abstract][Full Text] [Related]
34. Editorial: advances in the therapy of atrial fibrillation: incrementally progressive but not without missteps. Reiffel JA Curr Cardiol Rev; 2014 Nov; 10(4):295-6. PubMed ID: 24821655 [TBL] [Abstract][Full Text] [Related]
35. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation? Conde D Int J Cardiol; 2013 Oct; 169(2):95-6. PubMed ID: 24071384 [TBL] [Abstract][Full Text] [Related]
36. Vernakalant for the conversion of atrial fibrillation: the new kid on the block? Conde D; Baranchuk A Ann Noninvasive Electrocardiol; 2014 Jul; 19(4):299-302. PubMed ID: 24738652 [TBL] [Abstract][Full Text] [Related]
38. Dronedarone: an emerging therapy for atrial fibrillation. Rosei EA; Salvetti M Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270 [TBL] [Abstract][Full Text] [Related]
39. Dronedarone: an overview. Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093 [TBL] [Abstract][Full Text] [Related]
40. Dronedarone--a new alternative for management of atrial fibrillation. Hundal M; Garg RK Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):47-53. PubMed ID: 20001929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]